GlassScriptPhysician profile
Raisa D Camilo
NPI 1427048495
$1,611.60
in general payments reported to CMS, 2019-2025
23 companies · $35.90 in 2025
The $35.90 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $222 · 2021: $493 · 2022: $209 · 2023: $141 · 2024: $172 · 2025: $35.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $511.83 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $241.51 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Novo Nordisk INC | $208.78 | 2020-2024 | Rybelsus, Ozempic |
| Corcept Therapeutics | $72.47 | 2021-2024 | Korlym |
| Pfizer INC. | $70.64 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $62.93 | 2021-2023 | Qelbree |
| Amgen INC. | $52.44 | 2021-2024 | Repatha |
| Abbott Laboratories | $38.98 | 2023-2024 | Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.23 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.87 | 2019 | |
| Esperion Therapeutics, INC. | $30.69 | 2021 | |
| Sanofi Pasteur INC. | $30.37 | 2019-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.70 | 2022 | |
| Grt US Holding, INC. | $27.51 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $24.53 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.53 | 2024 | |
| Janssen Pharmaceuticals, INC | $17.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $16.64 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $16.02 | 2022 | |
| Genzyme Corporation | $15.55 | 2025 | |
| Cranial Technologies, INC | $15.22 | 2024 | Doc Band |
| Edwards Lifesciences Corporation | $13.51 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raisa Camilo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.